BIOMAT Database Logo BIOMAT Database Logo

[Protection of the islet apparatus in experimental alloxan diabetes]. 1982

B A Kudriashov, and Iu A Pytel', and G M Baskakova, and G A Sokolova, and L A Liapina

UI MeSH Term Description Entries
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D000496 Alloxan Acidic compound formed by oxidation of URIC ACID. It is isolated as an efflorescent crystalline hydrate.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

B A Kudriashov, and Iu A Pytel', and G M Baskakova, and G A Sokolova, and L A Liapina
[Function of the vestibular apparatus in experimental alloxan diabetes].
January 1950, Bollettino della Societa italiana di biologia sperimentale,
B A Kudriashov, and Iu A Pytel', and G M Baskakova, and G A Sokolova, and L A Liapina
Protection against alloxan diabetes.
March 1947, The Anatomical record,
B A Kudriashov, and Iu A Pytel', and G M Baskakova, and G A Sokolova, and L A Liapina
[Chronaxy of neuromuscular apparatus in alloxan diabetes].
January 1954, Voprosy fiziologii,
B A Kudriashov, and Iu A Pytel', and G M Baskakova, and G A Sokolova, and L A Liapina
[Experimental alloxan diabetes].
June 1952, Gazzetta medica italiana,
B A Kudriashov, and Iu A Pytel', and G M Baskakova, and G A Sokolova, and L A Liapina
[Effect of hypothermia and ACTH on the course of alloxan diabetes and the islet apparatus of the pancreas].
January 1962, Problemy endokrinologii i gormonoterapii,
B A Kudriashov, and Iu A Pytel', and G M Baskakova, and G A Sokolova, and L A Liapina
Chlorpromazine protection against alloxan diabetes.
July 1955, Metabolism: clinical and experimental,
B A Kudriashov, and Iu A Pytel', and G M Baskakova, and G A Sokolova, and L A Liapina
Experimental studies on islet cell changes in the pancreas, liver and kidneys in alloxan diabetes.
January 1970, Nauchni trudove na Visshiia meditsinski institut, Sofiia,
B A Kudriashov, and Iu A Pytel', and G M Baskakova, and G A Sokolova, and L A Liapina
The mechanism of alloxan protection in experimental atherosclerosis.
February 1954, The Journal of experimental medicine,
B A Kudriashov, and Iu A Pytel', and G M Baskakova, and G A Sokolova, and L A Liapina
[Recent studies on alloxan: experimental latent diabetes and the effect of radiation protection].
June 1967, Deutsche medizinische Wochenschrift (1946),
B A Kudriashov, and Iu A Pytel', and G M Baskakova, and G A Sokolova, and L A Liapina
The liver in experimental alloxan diabetes.
December 1946, Medecine et hygiene,
Copied contents to your clipboard!